Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study.
Raj DS, Sohn MB, Charytan DM, Himmelfarb J, Ikizler TA, Mehrotra R, Ramezani A, Regunathan-Shenk R, Hsu JY, Landis JR, Li H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Raj DS, et al. Kidney360. 2021 Jan 15;2(3):445-455. doi: 10.34067/KID.0006132020. eCollection 2021 Mar 25. Kidney360. 2021. PMID: 35369018 Free PMC article.
Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial.
Charytan DM, Hsu JY, Mc Causland FR, Waikar SS, Ikizler TA, Raj DS, Landis JR, Mehrotra R, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Charytan DM, et al. Among authors: raj ds. Kidney360. 2020 Oct 15;1(12):1380-1389. doi: 10.34067/KID.0004342020. eCollection 2020 Dec 31. Kidney360. 2020. PMID: 35372900 Free PMC article. Clinical Trial.
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Charytan DM, et al. Among authors: raj ds. Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23. Kidney Int. 2019. PMID: 30473139 Free PMC article. Clinical Trial.
A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
Dember LM, Hung A, Mehrotra R, Hsu JY, Raj DS, Charytan DM, Mc Causland FR, Regunathan-Shenk R, Landis JR, Kimmel PL, Kliger AS, Himmelfarb J, Ikizler TA; Hemodialysis Novel Therapies Consortium. Dember LM, et al. Among authors: raj ds. Kidney Int. 2022 Nov;102(5):1178-1187. doi: 10.1016/j.kint.2022.06.022. Epub 2022 Jul 19. Kidney Int. 2022. PMID: 35863559 Free PMC article. Clinical Trial.
Gut microbiome in chronic kidney disease.
Wing MR, Patel SS, Ramezani A, Raj DS. Wing MR, et al. Among authors: raj ds. Exp Physiol. 2016 Apr;101(4):471-7. doi: 10.1113/EP085283. Epub 2015 Oct 2. Exp Physiol. 2016. PMID: 26337794 Free article. Review.
Gut Microbiome in Chronic Kidney Disease.
Armani RG, Ramezani A, Yasir A, Sharama S, Canziani MEF, Raj DS. Armani RG, et al. Among authors: raj ds. Curr Hypertens Rep. 2017 Apr;19(4):29. doi: 10.1007/s11906-017-0727-0. Curr Hypertens Rep. 2017. PMID: 28343357 Review.
173 results